Rheumatoid arthritis (RA) is a disease with significant gender differences in its prevalence and clinical features. Interleukin (IL)-1 and tumor necrosis factor (TNF) a a produced by synoviocytes are principle inflammatory and destructive mediators of RA. We found that a potent androgen, 5a a-dihydrotestosterone (DHT) inhibits IL-1a a-induced production and mRNA expression of IL-8, IL-6 and IL-1b b from RA patient-derived fibroblastlike synovial cell line MH7A. Promoter analysis of the IL-8 gene revealed that nuclear factor (NF)-k kB activation is critical for its transcriptional activation by IL-1a a, and DHT inhibited the IL-1a a-induced NF-k kB activation in a manner dependent on the androgen receptor (AR). DHT also inhibited the effects of TNFa a on the cells overexpressed with AR, indicating that sufficient expression level of functional AR was necessary for the inhibitory effect of DHT on TNFa a. These results suggest that androgen contributes to the prevention against RA and its gender difference by inhibiting IL-1a a or TNFa a-induced proinflammatory cytokine production from synovial fibroblast-like cells by inhibiting NF-k kB activation in a manner depending on AR.
Rheumatoid arthritis (RA) is a disease resulting from a combination of environmental and genetic factors, 1) and is characterized by the chronic inflammation and hyperproliferation of synovial cells in multiple joints. Proinflammatory cytokines and chemokines produced by synoviocytes and infiltrating immune cells are implicated in the disease pathogenesis. 2) In synovial fluids of RA patients many cytokines and chemokines are present, including interleukin (IL)-1a, IL-1b, IL-2, IL-3, IL-4, IL-6, IL-8, IL-15, IL-17, interferon (IFN) g, tumor necrosis factor (TNF) a, TNFb, transforming growth factor b, granulocyte-macrophage colony-stimulating factor and macrophage inflammatory protein-3a (MIP-3a) (CCL20). 3, 4) Among these cytokines, TNFa, IL-1 and IL-6 are pivotal in the pathogenesis of the disease. IL-1 and TNFa increase the induction of cytokines, chemokines, proteases, prostaglandin E2, reactive oxygen intermediates, proliferation of synovial fibroblasts, cartilage degradation, infiltration of inflammatory cells, angiogenesis and fever. 5, 6) IL-1 is a major cytokine inducing cartilage degradation, and mediates cartilage degradation by TNFa. 7) IL-6 induces T cell growth, stimulates B cells and is a potent inducer of acute phase proteins. 8) Indeed an antibody against TNFa, a soluble receptor for TNFa, interleukin-1 receptor antagonist (IL-1ra) and an antibody against IL-6 appeared to be effective in the treatment of RA patients. [9] [10] [11] These cytokines form a network, inducting IL-1, IL-6 and chemokines by TNFa, and IL-6 and chemokines by IL-1. 5, 6, 8) Macrophage-lineage cells infiltrating synovial tissues produce IL-1b and TNFa, and fibroblast-like synovial cells produce IL-1a, IL-1b and IL-6. 12) RA occurs more frequently in women as is also true of other autoimmune diseases; the ratio of RA incidence in women to men is about 2-4 : 1.
13) Serum concentrations of dehydroepiandrosterone (DHEA) and estrone concentrations were lower and estradiol was higher in RA male patients compared with healthy controls, and estradiol correlated with the inflammation.
14) The levels of estrogen to androgen in synovial fluid are elevated in both male and female RA patients, 15) and the level of testosterone in synovial fluid is low in male RA patients as compared to normal individuals. 16) In addition, women have a more severe disease with a considerably lower remission rate than men. 17) Therefore, sex hormones are implicated in the gender difference in both the onset and progression of RA.
It is reported that synovial macrophages from RA patients metabolize testosterone to the bioactive metabolite 5a-dihydrotestosterone (DHT), and testosterone inhibits IL-1b production from the cells. 18) In contrast, the effects of androgen on the cytokine production from fibroblast-like synovial cells are largely unknown. We have reported that 17 beta-estradiol (E2) induced IL-1a mRNA expression, 19) whereas DHT inhibited TNFa-induced IL-1a mRNA expression in RA patient-derived fibroblast-like synovial cell line MH7A. 20) In this study, we examined the effect of DHT on induction of IL-8, IL-6 and IL-1b by IL-1a or TNFa in MH7A cells, and suggested that DHA inhibits the effects of IL-1a and TNFa by inhibiting nuclear factor (NF)-kB activation in a manner dependent on the androgen receptor (AR). 21) were cultured in DMEM with 100 U/ml of penicillin G, 100 mg/ml of streptomycin, 4 mM L-glutamine and 10% heat-inactivated FBS at 37°C in air containing 5% CO 2 . The day before the experiment, the culture medium was replaced by phenol red-free DMEM supplemented with 10% heat-inactivated FBS that had been pretreated with dextran-coated charcoal to remove endogenous androgen.
MATERIALS AND METHODS

Reagents
Measurement of Cytokine Level Protein levels of IL1b, IL-6 and IL-8 were determined by enzyme-linked immunosorbent assays (ELISA) kit according to the manufacturer's protocol using an Endogen Human IL-1b ELISA Set, human IL-6 ELISA Set and human IL-8 ELISA Set (BD Biosciences, U.S.A.).
Plasmids pGL3-kBwt and NF-kB mutant construct pGL3-kBm (for NF-kB reporter gene assay) were kindly provided by Dr. T. Okamoto (Nagoya City University Graduate School of Medical Sciences). pcDNA3-F-AR (AR expression vector) was kindly provided by Dr. A. Ariga (Faculty of Pharmaceutical Sciences, Hokkaido University). pcGL3-IL-8 (WT) and pGL3-IL-8 (mutant NF-kB) were generously furnishied by Dr. N. Mukaida (Cancer Research Institute, Kanazawa University). pGL4-activator protein (AP) (AP-1) 6 Luc, pGL4-CCAAT-enhancer-binding protein (C/EBP) (C/EBP) 6 -Luc, pGL4(NF-kB-like) 6 -Luc and pGL4-(Ig-kB) 6 Luc were generated by polymerase chain reaction (PCR).
Real Time PCR Analysis Assays were performed using an Applied Biosystems 7300 sequence detector (Applied Biosystems, Foster City, CA, U.S.A.) as described previously. 22) For the analysis of human IL-1b, IL-6 and IL-8, each amplification mixture (20 ml) was made to contain 80 ng cDNA, 10 ml Premix EX Taq TM (pPerfect Real Time) (RR039A) (Takara Bio, Japan), 1 ml PCR primer (forward and reverse primer), 0.4 ml Rox Reference Dye (Takara Bio), and distilled water. The reaction mixtures were incubated at 95°C for 10 s, followed by 40 cycles of 95°C for 15 s, 60°C for 1 min, and then cooled to 4°C. For glyceraldehyde-3-phosphate dehydrogenase (GAPDH), the reaction mixture (20 ml) contained 40 ng cDNA, 10 ml POWER SYBER Green PCR Master Mix (P/N 4367659) (Applied Biosystems), 2 ml PCR primer (forward and reverse primers) (5 mM), and distilled water. The reaction mixtures were incubated at 95°C for 10 min, followed by 40 cycles of 95°C for 15 s, 58.2°C for 1 min, 60°C for 30 s, 95°C for 15 s, and then cooled to 4°C. Data were analyzed with the ABI Sequence Detector's software. The results were expressed as meanϮS.D. for the relative expression levels compared with GAPDH, and minimum values of four independent experiments were used. The TaqMac probes and primers for IL-1b (Hs00174097 m1), IL-6 (Hs00174131 m1) and IL-8 (Hs00174103 m1) were obtained from Applied Biosystems. Primers for human GAPDH, forward primer 5Ј-cctgcaccaccaactgctta-3Ј and reverse primer, 5Ј-TCTTCTGGGTGGCAGTGATG-3Ј, were obtained from the Japan Genetic Institute (Sendai, Japan).
Transient Transfection and Luciferase Assays
The day before transient transfection of MH7A cells, the culture medium was replaced by phenol red-free DMEM supplemented with 10% heat-inactivated FBS that had been pretreated with dextran-coated charcoal to remove endogenous sex hormones. Reporter plasmid, AR expression plasmid and pCMV-b gal plasmid (for normalization of transfection effi- Western Blot Assay Cells were lysed in a buffer composed of 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1% Triton-X, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS), 50 mM NaF, 1 mM phenylmethylsulfonyl fluoride for, 10 mg/ml leupeptin and 50 mg/ml aprotinin by incubating for 30 min at 4°C. The proteins were separated by 8% SDSpolyacrylamide gel electrophoresis (PAGE) and were transferred to a polyvinylidene difloride (PVDF) microporous membrane, Immobilon TMPVDF (Millipore, Bedford, MA, U.S.A.). After blocking with 5% nonfat dry milk in Trisbuffered saline with 0.1% Tween 20, membranes were incubated with anti-IkBa (c-15) rabbit polyclonal antibody (Santa Cruz Biotechnology, Inc.), anti-b-actin (AC-15) mouse mAb (Sigma Chemical Co.) or anti-Flag M2 mouse monoclonal antibody (Sigma Chemical Co.), and then with horseradish peroxidase (HRP)-conjugated anti-rabbit immunoglobulin (Ig) G (Jackson ImmunoResearch, West Grove, PA, U.S.A.) or anti-mouse Ig HRP-linked whole antibody (GE Healthcare U.K., Ltd.). The reactive proteins were detected with enhanced chemiluminescence reagents (GE Healthcare U.K., Ltd.) and were analyzed by a chemiluminescence image analyzer, LAS-1000 (GE Healthcare U.K., Ltd.).
Statistic Analysis Statistical significance between two groups was examined using unpaired Student's t-test. The symbol * and * * indicates statistical significance at p values of 0.05 and 0.01 in figures, respectively. DHT alone did not influence the level of these cytokines. In contrast to the effect on IL-1a, DHT did not significantly inhibit the TNFa-induced IL-8, IL-6 and IL-1b production (data not shown). However, in the cells overexpressed with AR, DHT did exhibit the inhibitory effect (Figs. 1D-F) .
DHT Inhibits IL-1a a or TNFa a-Induced IL-8, IL-6 and IL-1b b mRNA Expression In order to determine whether the inhibitory effect of DHT was at the level of mRNA of these cytokines, we determined the effects of DHT on the mRNA expression of IL-8, IL-6 and IL-1b induced by IL-1a or TNFa. As shown in Figs 6 -Luc, pGL4-(NF-kB-like) 6 -Luc, pGL4-(C/EBP) 6 -Luc or pGL4-(AP-1) 6 -Luc activity in MH7A cells. MH7A cells were transiently transfected with pCMV-b-gal with or without pGL4-(Ig-kB) 6 -Luc, pGL4-(NF-kB-like) 6 Luc, pGL4-(C/EBP) 6 -Luc or pGL4-(AP-1) 6 -Luc. After 16 h, cells were treated with or without IL-1a (1000 U/ml) or TNFa (10 U/ml) for 24 h and luciferase activity was measured. Luciferase activtity was normalized by b-galactosidase activity and expressed as a percentage of control (untreated cells).
ulated by AP-1 or C/EBP as well, depending on cell type. 24) In order to confirm the critical role of NF-kB activation for the IL-1a or TNFa-induced transactivation of the IL-8 gene in MH7A cells, we performed the reporter gene assay using cells transfected with pGL4-(Ig-kB) 6 , pGL4-(NF-kB-like) 6 , pGL4-(C/EBP) 6 or pGL4-(AP-1) 6 . Each element except for Ig-kB was derived from the IL-8 promoter gene. As shown in Fig. 4 , luciferase activities from pGL4-(Ig-kB) 6 or pGL4-(NF-kB-like) 6 were markedly augmented by IL-1a or TNFa treatment, while those from pGL4-(C/EBP) 6 or pGL4-(AP-1) 6 were not at all or only slightly activated, indicating the importance of NF-kB activation in MH7A cells.
DHT Inhibits the IL-1a a or TNFa a-Induced NF-k kB Activation via AR In order to determine whether the inhibition of IL-1a or TNFa-induced NF-kB activation by DHA is dependent on AR, MH7A cells were transfected with the reporter plasmid for NF-kB with or without overexpression of AR, and then treated with or without IL-1a or TNFa in the presence or absence of DHT. As shown in Fig. 5, IL-1a or TNFa augmented luciferase activity from pGL4-(Ig-kB) 6 or pGL4-(NF-kB-like) 6 . DHT did not inhibit the IL-1a or TNFa-induced luciferase activity. However, in the cells overexpressed with AR, DHT did exhibit the inhibitory effect.
DHT Inhibits the IL-1a a or TNFa a-Induced Ik kB Degradation IkB degradation is a critical step for the activation of NF-kB. In order to determine whether DHT inhibits the IL-1a or TNFa-induced NF-kB activation by inhibiting Ik-B degradation, MH7A cells were treated with or without IL1a or TNFa in the presence or absence of DHT, and then IkB expression level was determined. As shown in Fig. 6 , IL1a or TNFa induced degradation of IkB. DHT significantly reversed the effect of IL-1a (Fig. 6A) . In contrast, this reversal effect was not observed in the cells without overexpression of AR (Fig. 4B) , but was observed in those overexpressed with AR (Fig. 6C) .
DISCUSSION
In this study we first showed that DHT inhibits IL-1a or TNFa-induced production of IL-1b, IL-6 and IL-8 from MH7A synoviocytes. The inhibitory effect of DHT was at the level of mRNA expression of these cytokines. We further demonstrated that DHT inhibits IL-1a or TNFa-induced promoter activity of the IL-8 gene, which was dependent on AR. It is reported that the IL-8 gene activation is regulated by NF-kB, C/EBP and AP-1, each of them alone or in synergy, depending on cell type. 23) In MH7A cells the NF-kB binding site in the promoter region of the IL-8 gene appeared to be critical for the IL-1a or TNFa-induced transactivation of the gene. This was confirmed by the observation that NF-kB, ei- ther IL-8 gene-or Ig-kB-derived, was markedly activated by IL-1a or TNFa, while C/EBP and AP-1 were not at all or only slightly activated. In addition, DHT inhibited NF-kB activation as demonstrated by the inhibition of IL-1a or TNFa-induced activation of the reporter gene with NF-kB in a manner dependent on AR. In these experiments DHT inhibited the IL-1a-induced production and mRNA expression of IL-1b, IL-6 and IL-8 without overexpression of AR. The IL1a-dependent degradation of IkB, a critical step for NF-kB activation, was also inhibited by DHT without overexpression of AR. However, such overexpression was necessary for the inhibitory effects of DHT on the IL-1a-induced promoter activation of the IL-8 gene. Therefore, the expression level of endogenous AR alone is not sufficient for DHT to exert its maximum effect. In contrast to IL-1a, the inhibitory effect of DHT on all the effects of TNFa required overexpression of AR. It is probable that signals from TNFa are stronger than those from IL-1a in the cells.
AR is a member of a group of four closely related steroid receptors, the other members of which are glucocorticoid receptor, mineralocorticoid receptor, and progesterone receptor. 25) AR consists of four domains, an N-terminal domain that is involved in transcriptional regulation, a DNA-binding domain, a hinge region and a C-terminal ligand-binding domain. The ligand binds to AR in the cytoplasm, and then the ligand-activated AR forms a homodimer, translocates into nucleus, binds to target DNA, interacts with coactivators and induces transcription of the genes. The mechanism by which DHT/AR inhibits NF-kB activation is not yet known. In COS-1 cells overexpression of RelA (p65) repressed AR-mediated transactivation with weak interaction between AR and RelA, 26) and in prostate cancer LNCaP cells DHT suppressed NF-kB activity accompanying a slight increase of IkB level. 27) We showed that DHT inhibits IL-1a or TNFa-induced IkB degradation. However, the precise mechanism remains to be elucidated.
It is reported that mRNA and protein of AR are expressed in the synovium tissue. Relative abundance of AR mRNA was significantly lower in RA than in non-inflamed synovial tissue, and the expression level of AR protein was significantly higher in lining cells and fibroblasts than that in inflammatory cells.
28) It is also reported that AR is expressed in synoviocytes, and that DHT inhibits the IL-1b-induced production of IL-6. 29) Therefore, it is possible that DHT has a preventive effect against the onset and/or development of RA, which is dependent on the expression of functional AR in the synovium tissue.
IL-8 is a chemokine for neutrophils and T cells, which is strongly induced by IL-1a, IL-1b or TNFa. The pathogenic role of IL-8 in RA was suggested by the observation that as the disease worsens and the cell count infiltrating into synovium increases, the polymorphonuclear leucocyte becomes the predominant cell type.
30) The IL-8 level was higher in synovial fluid from RA patients than in synovial fluid from osteoarthritis patients or from patients with other arthritides. Synovial tissue fibroblasts release only small amounts of constitutive IL-8 but could be induced to produce IL-8 by stimulation with either IL-1b or TNFa, 31) which is in agreement with our study. We also showed that DHT inhibits IL1a or TNFa-induced production and mRNA of IL-1b and IL-6. NF-kB activation is critical for induction of these cytokines. Along with TNFa, IL-1b and IL-6 are major players in the onset and development of RA. [5] [6] [7] Therefore, our study suggests that DHT is a negative regulator of the pathogenesis of RA by inhibiting TNFa or IL-1-induced production of proinflammatory cytokines from synovial fibroblastlike cells, thereby contributing to the gender differences of RA. 
